fibromyalgia
FIBROMYALGIA

Fibromyalgia is a clinical syndrome wherein the patient experiences generalized pain and fatigue that cannot be explained by the presence of any other disorder.
It is often considered to be psychosomatic or psychogenic in nature.
It is found in approximately 2% of the population and the prevalence increases with age, most common in women 20-55 year of age

Patient Education

  • Critical in the optimal management of FM
  • Goal is to help the patient understand & manage the symptoms optimally, reduce dependence on the medical system & work effectively w/in the system
  • Provide patient & family w/ information about FM, diagnosis & all treatment options
  • It should be emphasized that FM is a real disease & is not a deforming or a deteriorating disorder
    • Great majority of patients have normal & active lives
  • Emphasize the role of stress & mood disorder, encourage FM patients to learn simple relaxation techniques & to consider formal stress-reduction programs
  • Reinforce the importance of proper sleep hygiene
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
16 Apr 2018
Ofatumumab appears to be effective and well-tolerated in the treatment of patients with long-standing systemic lupus erythematosus, offering an alternative to the B cell–depleting agent rituximab, according to a study.
13 Apr 2018
A recent study has shown that the herpes zoster (HZ) vaccine induces varicella zoster virus (VZV)-specific cellular and humoral responses in patients with rheumatic arthritis (RA).
15 Apr 2018
Compared to other tumour necrosis factor–α inhibitors (TNFi), infliximab remains superior in reducing Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) at 12 weeks, results of a network meta-analysis (NMA) have shown. However, it was sensitive to inclusion of an open-label trial, and its efficacy faded at 24 weeks.